Skip to main content
PMC home page
American Journal of Public Health logoLink to American Journal of Public Health
. 1995 Jun;85(6):786–790. doi: 10.2105/ajph.85.6.786

Community-based tuberculin screening in Montreal: a cost-outcome description.

N Adhikari 1, R Menzies 1
PMCID: PMC1615513  PMID: 7762710

Abstract

OBJECTIVES. This study describes the costs and outcomes of community-based tuberculin screening programs conducted between 1987 and 1991 in Montreal, Quebec, Canada. METHODS. Follow-up information was abstracted from hospital records of all reactors detected in tuberculin screening of students in grades 6 and 10, of first-year health professional students, and of workers aged 18 to 25 in a number of workforces. Screening costs were estimated directly from survey records, and follow-up costs were estimated from the annual financial report of the Montreal Chest Hospital for 1989/90. RESULTS. Of 7669 persons tested, 782 (10.2%) had positive results and 757 (9.9%) were referred to a clinic. Of those, 525 (6.8% of the original 7669) reported, 293 (3.8%) were prescribed therapy, and 154 (2.0%) were compliant. In Canadian dollars, screening cost $5.70 per person tested and $56 per tuberculin reactor detected, but follow-up of reactors accounted for 73% of the total program cost of $13,455 to $18,753 per case of tuberculosis prevented. CONCLUSIONS. Because of high rates of patient and provider noncompliance, a tuberculin screening program was much less cost-effective than anticipated. Screening costs must be targeted to the highest risk populations, and compliance with recommendations for preventive therapy must be maximized.

Full text

PDF
790

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barry M. A., Shirley L., Grady M. T., Etkind S. W., Almeida C., Bernardo J., Lamb G. A. Tuberculosis infection in urban adolescents: results of a school-based testing program. Am J Public Health. 1990 Apr;80(4):439–441. doi: 10.2105/ajph.80.4.439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bloom B. R. Tuberculosis. Back to a frightening future. Nature. 1992 Aug 13;358(6387):538–539. doi: 10.1038/358538b0. [DOI] [PubMed] [Google Scholar]
  3. Clague J. E., Fields P., Graham D. R., Davies P. D. Screening for tuberculosis: current practices and attitudes of hospital workers. Tubercle. 1991 Dec;72(4):265–267. doi: 10.1016/0041-3879(91)90052-t. [DOI] [PubMed] [Google Scholar]
  4. Colice G. L. Decision analysis, public health policy, and isoniazid chemoprophylaxis for young adult tuberculin skin reactors. Arch Intern Med. 1990 Dec;150(12):2517–2522. [PubMed] [Google Scholar]
  5. Dash L. A., Comstock G. W., Flynn J. P. Isoniazid preventive therapy: Retrospect and prospect. Am Rev Respir Dis. 1980 Jun;121(6):1039–1044. doi: 10.1164/arrd.1980.121.6.1039. [DOI] [PubMed] [Google Scholar]
  6. Fitzgerald J. M., Gafni A. A cost-effectiveness analysis of the routine use of isoniazid prophylaxis in patients with a positive Mantoux skin test. Am Rev Respir Dis. 1990 Oct;142(4):848–853. doi: 10.1164/ajrccm/142.4.848. [DOI] [PubMed] [Google Scholar]
  7. Fox W. Compliance of patients and physicians: experience and lessons from tuberculosis-I. Br Med J (Clin Res Ed) 1983 Jul 2;287(6384):33–35. doi: 10.1136/bmj.287.6384.33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Geiseler P. J., Nelson K. E., Crispen R. G., Moses V. K. Tuberculosis in physicians: a continuing problem. Am Rev Respir Dis. 1986 May;133(5):773–778. [PubMed] [Google Scholar]
  9. Glassroth J., Bailey W. C., Hopewell P. C., Schecter G., Harden J. W. Why tuberculosis is not prevented. Am Rev Respir Dis. 1990 May;141(5 Pt 1):1236–1240. doi: 10.1164/ajrccm/141.5_Pt_1.1236. [DOI] [PubMed] [Google Scholar]
  10. Halperin S. A., Langley J. M. Evaluation of a tuberculosis screening program at a children's hospital. Am J Infect Control. 1992 Feb;20(1):19–23. doi: 10.1016/s0196-6553(05)80120-8. [DOI] [PubMed] [Google Scholar]
  11. Judson F. N., Sbarbaro J. A., Tapy J. M., Cohn D. L. Tuberculosis screening. Evaluation of a food handlers' program. Chest. 1983 Jun;83(6):879–882. doi: 10.1378/chest.83.6.879. [DOI] [PubMed] [Google Scholar]
  12. Menzies R., Rocher I., Vissandjee B. Factors associated with compliance in treatment of tuberculosis. Tuber Lung Dis. 1993 Feb;74(1):32–37. doi: 10.1016/0962-8479(93)90066-7. [DOI] [PubMed] [Google Scholar]
  13. Menzies R., Vissandjee B., Amyot D. Factors associated with tuberculin reactivity among the foreign-born in Montreal. Am Rev Respir Dis. 1992 Sep;146(3):752–756. doi: 10.1164/ajrccm/146.3.752. [DOI] [PubMed] [Google Scholar]
  14. Menzies R., Vissandjee B. Effect of bacille Calmette-Guérin vaccination on tuberculin reactivity. Am Rev Respir Dis. 1992 Mar;145(3):621–625. doi: 10.1164/ajrccm/145.3.621. [DOI] [PubMed] [Google Scholar]
  15. Menzies R., Vissandjee B., Rocher I., St Germain Y. The booster effect in two-step tuberculin testing among young adults in Montreal. Ann Intern Med. 1994 Feb 1;120(3):190–198. doi: 10.7326/0003-4819-120-3-199402010-00003. [DOI] [PubMed] [Google Scholar]
  16. Miller B., Snider D. E., Jr Physician noncompliance with tuberculosis preventive measures. Am Rev Respir Dis. 1987 Jan;135(1):1–2. doi: 10.1164/arrd.1987.135.1.1. [DOI] [PubMed] [Google Scholar]
  17. Raad I., Cusick J., Sherertz R. J., Sabbagh M., Howell N. Annual tuberculin skin testing of employees at a university hospital: a cost-benefit analysis. Infect Control Hosp Epidemiol. 1989 Oct;10(10):465–469. doi: 10.1086/645922. [DOI] [PubMed] [Google Scholar]
  18. Rose D. N., Schechter C. B., Fahs M. C., Silver A. L. Tuberculosis prevention: cost-effectiveness analysis of isoniazid chemoprophylaxis. Am J Prev Med. 1988 Mar-Apr;4(2):102–109. [PubMed] [Google Scholar]
  19. Rose D. N., Schechter C. B., Silver A. L. The age threshold for isoniazid chemoprophylaxis. A decision analysis for low-risk tuberculin reactors. JAMA. 1986 Nov 21;256(19):2709–2713. [PubMed] [Google Scholar]
  20. Snider D. E., Jr, Caras G. J., Koplan J. P. Preventive therapy with isoniazid. Cost-effectiveness of different durations of therapy. JAMA. 1986 Mar 28;255(12):1579–1583. [PubMed] [Google Scholar]
  21. Sumartojo E. When tuberculosis treatment fails. A social behavioral account of patient adherence. Am Rev Respir Dis. 1993 May;147(5):1311–1320. doi: 10.1164/ajrccm/147.5.1311. [DOI] [PubMed] [Google Scholar]
  22. Taylor W. C., Aronson M. D., Delbanco T. L. Should young adults with a positive tuberculin test take isoniazid? Ann Intern Med. 1981 Jun;94(6):808–813. doi: 10.7326/0003-4819-94-6-808. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES